Quantitative analysis of 105 ER+ samples and 29 triple negative samples showed a significant higher average staining in samples from triple negative tumors as compared to estrogen positive tumor samples (p < 0.0001, Fig. 7C). This evidence concerns the gene ESR1 and neoplasm.